Posts

Definium Therapeutics Prices $700 Million Upsized Public Offering

on

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

on

WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban

on

Laverock Therapeutics Awarded Over £2.2M in Innovation Grants for AI‑Powered Platform and Non‑Oncology Expansion

on

Human Longevity launches newco, teams with Insilico for AI‑powered longevity research — May 28, 2026 update

on

FDA names Tracy Beth Heg as acting CDER chief

on

Recent Developments on Vinay Prasad's Leaked FDA Memo, Alzheimer's Disease Updates, and Next-Gen Obesity Drugs

on

Top Drug Regulator Richard Pazdur to Retire from FDA Amid Industry Concerns

on

As Drug Resistance Rises, GramEye and GSK Advance New AI-Led Infectious Disease Research

on

Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights

on

Roche Pays $55M Upfront to Manifold Bio in $2B+ Deal for AI-Guided Next-Gen Brain Shuttles

on

Vinay Prasad Returns to the FDA With Fewer Titles and a Lower Profile

on

Data Lakes & FAIR Principles: Making Scientific Data Accessible and Actionable

on

AstraZeneca and CSPC Enter $5.3B AI-Driven Drug Discovery Pact in China

on

Sanofi Announces $20 Billion US Investment Over Five Years

on

Accelerating Clinical Trial Excellence: A Seamless IRB & IBC Collaboration

on

Exclusive: Vertex drops AAV gene therapy research, tRNA therapy partnership

on

Federal Judge Blocks NIH Grant Caps as HHS Appeals Ruling

on

Senators grill Trump's NIH nominee on vaccines and funding

on

Legal Battle Erupts as Deerfield Accuses Alcon of Obstructing Aurion Biotech's IPO Plans

on